FNY Investment Advisers’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Sell |
3,500
-7,836
| -69% | -$338K | 0.06% | 245 |
|
|
2025
Q1 | $391K | Sell |
11,336
-2,414
| -18% | -$83.3K | 0.24% | 93 |
|
|
2024
Q4 | $377K | Buy |
13,750
+5,100
| +59% | +$140K | 0.2% | 107 |
|
|
2024
Q3 | $220K | Buy |
8,650
+2,900
| +50% | +$73.8K | 0.11% | 161 |
|
|
2024
Q2 | $145K | Buy |
5,750
+2,000
| +53% | +$50.4K | 0.1% | 144 |
|
|
2024
Q1 | $115 | Buy |
+3,750
| New | +$115 | 0.07% | 169 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 444 |
|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$17K | – | 568 |
|
|
2023
Q2 | $17K | Hold |
1,000
| – | – | 0.02% | 253 |
|
|
2023
Q1 | $16K | Buy |
+1,000
| New | +$16K | 0.02% | 288 |
|
|
2019
Q3 | – | Sell |
-256
| Closed | -$6K | – | 794 |
|
|
2019
Q2 | $6K | Buy |
+256
| New | +$6K | ﹤0.01% | 637 |
|